130 related articles for article (PubMed ID: 16820914)
1. Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma.
Belhocine T; Pierard GE; Frühling J; Letesson G; Bolle S; Hustinx R; Dargent JL; Flamen P; Rigo P
Oncol Rep; 2006 Aug; 16(2):347-52. PubMed ID: 16820914
[TBL] [Abstract][Full Text] [Related]
2. [Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].
Amal G; Sara T; Ghofrane CS; Malika AI; Majdouline H; Souha S; Abdelatif B; Najoua T; Ghita B; Zineb B; Nabil C
Pan Afr Med J; 2016; 23():156. PubMed ID: 27303574
[TBL] [Abstract][Full Text] [Related]
3. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O
Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
[TBL] [Abstract][Full Text] [Related]
5. Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.
Epstude M; Tornquist K; Riklin C; di Lenardo F; Winterhalder R; Hug U; Strobel K
Clin Nucl Med; 2013 Apr; 38(4):283-4. PubMed ID: 23429397
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma.
Sollini M; Taralli S; Milella M; Erba PA; Rubagotti S; Fraternali A; Roncali M; Moscarella E; Perotti G; Rufini V; Versari A
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1507-11. PubMed ID: 26446694
[TBL] [Abstract][Full Text] [Related]
7. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
Concannon R; Larcos GS; Veness M
J Am Acad Dermatol; 2010 Jan; 62(1):76-84. PubMed ID: 20082888
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma.
Lu Y; Fleming SE; Fields RC; Coit DG; Carrasquillo JA
Clin Nucl Med; 2012 Aug; 37(8):759-62. PubMed ID: 22785503
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.
Siva S; Byrne K; Seel M; Bressel M; Jacobs D; Callahan J; Laing J; Macmanus MP; Hicks RJ
J Nucl Med; 2013 Aug; 54(8):1223-9. PubMed ID: 23753187
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.
Hawryluk EB; O'Regan KN; Sheehy N; Guo Y; Dorosario A; Sakellis CG; Jacene HA; Wang LC
J Am Acad Dermatol; 2013 Apr; 68(4):592-599. PubMed ID: 23127473
[TBL] [Abstract][Full Text] [Related]
11. 15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.
Byrne K; Siva S; Chait L; Callahan J; Bressel M; Seel M; MacManus MP; Hicks RJ
J Nucl Med; 2015 Sep; 56(9):1328-33. PubMed ID: 26159592
[TBL] [Abstract][Full Text] [Related]
12. Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
Ben-Haim S; Garkaby J; Primashvili N; Goshen E; Shapira R; Davidson T; Israel O; Epelbaum R
Nucl Med Commun; 2016 Aug; 37(8):865-73. PubMed ID: 27092665
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTATATE-PET/CT positive metastatic lymph node in a 69-year-old woman with Merkel cell carcinoma.
Schneider C; Schlaak M; Bludau M; Markiefka B; Schmidt MC
Clin Nucl Med; 2012 Nov; 37(11):1108-11. PubMed ID: 22996252
[TBL] [Abstract][Full Text] [Related]
14. Interest of (18)F-FDG PET-CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients.
Maury G; Dereure O; Du-Thanh A; Mariano-Goulart D; Guillot B
J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1420-7. PubMed ID: 21366705
[TBL] [Abstract][Full Text] [Related]
15. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
Poulsen M; Macfarlane D; Veness M; Estall V; Hruby G; Kumar M; Pullar A; Tripcony L; Rischin D
J Med Imaging Radiat Oncol; 2018 Jun; 62(3):412-419. PubMed ID: 29405630
[TBL] [Abstract][Full Text] [Related]
16. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.
Lim CS; Whalley D; Haydu LE; Murali R; Tippett J; Thompson JF; Hruby G; Scolyer RA
Ann Surg Oncol; 2012 Oct; 19(11):3325-34. PubMed ID: 22820936
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 68 Ga-DOTATATE PET/CT and 68 Ga-Pentixiafor PET/CT Imaging in a Case of Merkel Cell Carcinoma.
Rao Z; Zhang Y; Liu L; Wang M; Zhang C
Clin Nucl Med; 2023 Apr; 48(4):339-341. PubMed ID: 36727900
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET.
Peloschek P; Novotny C; Mueller-Mang C; Weber M; Sailer J; Dawid M; Czerny C; Dudczak R; Kletter K; Becherer A
Eur J Radiol; 2010 Feb; 73(2):317-23. PubMed ID: 19108971
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan.
Golan H; Volkov O; Linchinsky O; Melloul M
Nucl Med Rev Cent East Eur; 2005; 8(2):135-6. PubMed ID: 16437401
[TBL] [Abstract][Full Text] [Related]
20. Peptide receptor radionuclide therapy of Merkel cell carcinoma using (177)lutetium-labeled somatostatin analogs in combination with radiosensitizing chemotherapy: a potential novel treatment based on molecular pathology.
Salavati A; Prasad V; Schneider CP; Herbst R; Baum RP
Ann Nucl Med; 2012 May; 26(4):365-9. PubMed ID: 22361935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]